Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A O Mueck

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Climacteric : the Journal of the International Menopause Society|March 22, 2012
Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesteroneA O Mueck
Panminerva Medica|April 12, 2003
Statins and direct vascular actionsA O Mueck, H Seeger
Climacteric : the Journal of the International Menopause Society|May 12, 2015
Estrogen as a new option for prevention and treatment of breast cancer – does this need a 'time gap'?A O Mueck, H Seeger
Endocrine-Related Cancer|May 28, 2004
Hormone therapy after endometrial cancerA O Mueck, H Seeger
Steroids|March 11, 2010
2-Methoxyestradiol--biology and mechanism of actionA O Mueck, H Seeger
Climacteric : the Journal of the International Menopause Society|May 31, 2022
Primary choice of estrogen and progestogen as components for HRT: a clinical pharmacological viewX Ruan, A O Mueck
Climacteric : the Journal of the International Menopause Society|April 17, 2023
The WHO claims estrogens are 'carcinogenic': is this true?X Ruan, A O Mueck
Panminerva Medica|April 25, 2006
The effect of estradiol metabolites and progestogens on the proliferation of human ovarian cancer cellsH Seeger, A O Mueck
Climacteric : the Journal of the International Menopause Society|October 16, 2019
Will estradiol/progesterone capsules for oral use become the best choice for menopausal hormone therapy?A O Mueck, X Ruan
Zentralblatt Fur Gynakologie|April 11, 2000
[Clinical relevance of drug interactions between sexual steroids and other medications]A O Mueck, T Römer
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Climacteric : the Journal of the International Menopause Society|March 22, 2012
Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesteroneA O Mueck
Panminerva Medica|April 12, 2003
Statins and direct vascular actionsA O Mueck, H Seeger
Climacteric : the Journal of the International Menopause Society|May 12, 2015
Estrogen as a new option for prevention and treatment of breast cancer – does this need a 'time gap'?A O Mueck, H Seeger
Endocrine-Related Cancer|May 28, 2004
Hormone therapy after endometrial cancerA O Mueck, H Seeger
Steroids|March 11, 2010
2-Methoxyestradiol--biology and mechanism of actionA O Mueck, H Seeger
Climacteric : the Journal of the International Menopause Society|May 31, 2022
Primary choice of estrogen and progestogen as components for HRT: a clinical pharmacological viewX Ruan, A O Mueck
Climacteric : the Journal of the International Menopause Society|April 17, 2023
The WHO claims estrogens are 'carcinogenic': is this true?X Ruan, A O Mueck
Panminerva Medica|April 25, 2006
The effect of estradiol metabolites and progestogens on the proliferation of human ovarian cancer cellsH Seeger, A O Mueck
Climacteric : the Journal of the International Menopause Society|October 16, 2019
Will estradiol/progesterone capsules for oral use become the best choice for menopausal hormone therapy?A O Mueck, X Ruan
Zentralblatt Fur Gynakologie|April 11, 2000
[Clinical relevance of drug interactions between sexual steroids and other medications]A O Mueck, T Römer
Pageof 13